Skip to content
‹ Back to IndustriesSciences

What AI Means for Future Scientists

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly. History shows that technology does indeed change the nature of work. Perhaps the most dramatic example of this was the industrial revolution during the late 18th and…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Samuel Miller · · AiArtificial IntelligenceAutomationHuman Jobs
Share
What AI Means for Future Scientists

Key takeaways

01

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly.

02

History shows that technology does indeed change the nature of work.

03

Perhaps the most dramatic example of this was the industrial revolution during the late 18th and…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly. History shows that technology does indeed change the nature of work. Perhaps the most dramatic example of this was the industrial revolution during the late 18th and early 19th centuries that saw Europe and America transform from agrarian states to mechanized giants powered by coal and whale oil.

A New Revolution?

Today a quieter but no less drastic shift is taking place as mobile technology, blockchain, and artificial intelligence (AI), among other digital technologies, change the nature of work for many. While a first reaction might be to worry for the safety of human jobs, it is more accurate to say that technology changes the nature of certain jobs.

For example, ATMs did not remove the job of the bank teller, it simply altered their primary role from dispensing cash, to opening accounts and other clerical tasks.

The AI Effect

Perhaps the most disruptive, and ethically vague, of these new technologies is AI. One big concern related to AI is how it will affect jobs that require advanced quantitative skills, such as those in the scientific fields. Obviously, the scientific fields encompass a great deal of jobs requiring an equally diverse set of skills and qualifications. For the purposes of this article, we are discussing jobs that require higher degree such as an MS/Ph.D, or a medical qualification such as an MD.

Beginning with the assumption that these types of jobs are more at risk of artificial intelligence automation. Jobs in scientific fields are by and large more quantitative than their counterparts in the humanities or social sciences. Quantitative work is often formulaic by nature, and therefore capable of being done by highly-intelligent computers. Certain lab processes such as component testing are already being done by machines.

However, many scientific fields also require highly specific kinds of qualitative and ethical reasoning as well. This can most easily be seen in the medical fields, where a certain amount of humanity is required to diagnose and understand medical tests.

What it Means for Science

A recent article published by a career radiologist for The Scientist magazine highlights the delicate human decisions he must make every day, decisions that, at least currently, artificial intelligence is incapable of making. He demonstrates how AI is very good at identifying the fact based “what” questions, but not the judgement based “why’s.”

These are insights based on human experience and understanding that are incredibly difficult if not impossible to program. This is the human strength of the sciences and leveraging, cultivating this advantage should become a priority for educators and institutions in the near future.

Emphasizing the human side of the sciences and making it a bigger part of the field, will help prevent AI from automating science field jobs. And it is not just the sciences; Re-discovering the humanities has been a growing movement in areas such as business as well, where fields like ethical philosophy and creative design thinking have become popular to not just avoid automation, but to inject some meaning and, well, humanity into the field. At the end of the day, machines are not human and, at least for now, there are somethings that humans are just better at.

For the latest news, videos, and podcasts in the Science Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – twitter.com/ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

SM
Samuel Miller
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

UCB commits to Veeva Vault CRM for unified engagement

UCB commits to Veeva Vault CRM for unified engagement

UCB has committed to Veeva Vault CRM, which Veeva's release presents as an agentic CRM platform to drive unified engagement worldwide. Executives from both companies describe it as a foundation for commercial execution, while the AI claims, including the Agentic Call Report, come from Veeva's product description. No go-live date or financial terms were given.

  • 01The executive statements focus on Vault CRM as a foundation. The AI pitch, including the Agentic Call Report, comes from Veeva’s product description.
  • 02Veeva says the Agentic Call Report turns field call records into "Commercial Evidence" about treatment barriers that went unseen before. If that works, call-report data becomes something UCB can analyze.
  • 03Neither company disclosed a go-live date or financial terms. The first rollout milestone UCB names will be the signal that the move is actually happening.

Nov 7, 2026

Why ISPE put peptide and oligo facility design in one guide

Why ISPE put peptide and oligo facility design in one guide

ISPE's new Baseline Guide covers oligonucleotide and peptide facility design in one document, says Jim Love of CRB. It pairs a GMP survey of existing plants with a sustainability outlook and a piping safety framework for scale-up, while FDA's oligonucleotide guidances under dockets opened in 2022 and 2024 remain the regulator's own reference.

  • 01Peptide plants inherited API chemistry thinking and oligo plants biotech thinking; ISPE’s guide puts both modalities in one facility document with both inheritances.
  • 02The guide has three parts: a GMP survey of existing oligo and peptide plants, a forecast of how sustainability and scale will change the processes, and a safety framework for connective piping and equipment.
  • 03FDA keeps its own oligonucleotide-specific guidances under dockets opened in 2022 and 2024, so the ISPE guide works as an industry consensus alongside regulation rather than in place of it.

Nov 5, 2026

Collagen builder Astrion outdrew AstraGin at NuLiv's Bangkok booth

Collagen builder Astrion outdrew AstraGin at NuLiv's Bangkok booth

NuLiv Science says Astrion, its collagen-building ingredient, drew more interest than AstraGin at Vitafoods Asia 2026 in Bangkok, held September 2 to 4. Brands also asked for probiotic strains for pet weight loss, children, and women's health. New trials for AstraGin in Nutrients and Senactiv provide updated evidence for these distinct ingredients.

  • 01At Vitafoods Asia 2026 in Bangkok, Astrion drew more booth interest than AstraGin, NuLiv’s absorption flagship.
  • 02NuLiv says probiotic requests are now split by pet, child and life stage, and the show preview lists strains for women’s health, emotional wellbeing and the gut-muscle axis.
  • 03A newly published crossover trial in Nutrients found AstraGin raised branched-chain amino acid absorption and grip strength in adults aged 60 to 80.

Nov 5, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

SM
Samuel Miller

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512